Study to Evaluate Safety & Efficacy of Sarecycline in Treatment of Acne
- First Posted Date
- 2014-12-19
- Last Posted Date
- 2019-02-15
- Lead Sponsor
- Almirall, S.A.
- Target Recruit Count
- 968
- Registration Number
- NCT02320149
- Locations
- 🇺🇸
Warner Chilcott Research Site (Site #106), Chicago, Illinois, United States
🇺🇸Warner Chilcott Research Site (Site #102), Miami, Florida, United States
🇺🇸Warner Chilcott Research Site (Site #145), Miami, Florida, United States
Study To Evaluate The Efficacy And Safety Of Actikerall® Solution In Patients With Grade I-II Actinic Keratoses
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2014-11-13
- Last Posted Date
- 2016-08-05
- Lead Sponsor
- Almirall, S.A.
- Target Recruit Count
- 166
- Registration Number
- NCT02289768
- Locations
- 🇩🇪
Almirall Investigational Site #2, Selters, Germany
🇩🇪Almirall Investigational Site #1, Bochum, Germany
🇩🇪Almirall Investigational Site #6, Bonn, Germany
Efficacy and Safety of Tazarotene Gel in Nail Psoriasis
- First Posted Date
- 2014-09-10
- Last Posted Date
- 2015-06-10
- Lead Sponsor
- Almirall, S.A.
- Target Recruit Count
- 66
- Registration Number
- NCT02235480
- Locations
- 🇩🇪
Investigational site 4, Berlin, Germany
🇩🇪Investigational 2, Hamburg, Germany
🇩🇪Investigational site 1, Hamburg, Germany
A Intra-individual Comparison to Investigate the Efficacy and the Safety of LAS41004 Formulation in Mild to Moderate Psoriasis
- First Posted Date
- 2014-07-02
- Last Posted Date
- 2015-06-10
- Lead Sponsor
- Almirall, S.A.
- Target Recruit Count
- 40
- Registration Number
- NCT02180464
- Locations
- 🇩🇪
Site 1, Hamburg, Germany
Photoallergy Potential of Dapsone Gel in Healthy Volunteers
- First Posted Date
- 2014-04-21
- Last Posted Date
- 2018-10-09
- Lead Sponsor
- Almirall, S.A.
- Target Recruit Count
- 58
- Registration Number
- NCT02117739
Dermal Tolerability of Dapsone Gel in Healthy Volunteers
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2014-04-21
- Last Posted Date
- 2018-10-09
- Lead Sponsor
- Almirall, S.A.
- Target Recruit Count
- 237
- Registration Number
- NCT02117752
Efficacy, Tolerability and Safety of LAS41004 Formulations in a Psoriasis Plaque Test
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2014-04-11
- Last Posted Date
- 2014-06-09
- Lead Sponsor
- Almirall, S.A.
- Target Recruit Count
- 18
- Registration Number
- NCT02111499
- Locations
- 🇩🇪
proDERM GmbH, Schenefeld, Schleswig-Holstein, Germany
Phototoxicity Test of Dapsone Gel in Healthy Volunteers
- First Posted Date
- 2014-04-09
- Last Posted Date
- 2018-10-09
- Lead Sponsor
- Almirall, S.A.
- Target Recruit Count
- 33
- Registration Number
- NCT02108483
A Single-dose, Randomised, Crossover, Placebo-controlled Study Assessing Two Fixed-dose Combinations of Inhaled Long-acting Beta-agonist and Corticosteroid
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2014-03-21
- Last Posted Date
- 2014-05-22
- Lead Sponsor
- Almirall, S.A.
- Target Recruit Count
- 30
- Registration Number
- NCT02094274
- Locations
- 🇩🇪
Almirall Investigational Site #1, Berlin, Germany
🇬🇧Almirall Investigational Site #2, Harrow, United Kingdom
Safety and Efficacy Study of Dapsone Gel in Patients With Acne Vulgaris
- First Posted Date
- 2013-11-01
- Last Posted Date
- 2018-10-09
- Lead Sponsor
- Almirall, S.A.
- Target Recruit Count
- 2238
- Registration Number
- NCT01974323
© Copyright 2024. All Rights Reserved by MedPath